论文部分内容阅读
目的:观察参松养心胶囊联合胺碘酮预防房颤复发及对心功能的影响。方法:对83例转复窦律的房颤患者,随机分为对照组41例,治疗组42例;对照组单用胺碘酮治疗,治疗组应用参松养心胶囊联合胺碘酮;观察治疗6个月后房颤及阵发性房颤发生率、左室舒张末期内径及左室射血分数、血清脑钠肽(BNP)及动态心电图的变化。结果:治疗组房颤发生率明显低于对照组(P<0.05);2组患者左室舒张期内径,左室射血分数无显著性差异,但治疗组血清BNP显著优于对照组(P<0.05)。结论:参松养心胶囊联合胺碘酮能有效预防房颤复发,且能改善心功能。
Objective: To observe the effect of Shensong Yangxin Capsule combined with amiodarone on the prevention of recurrent atrial fibrillation and cardiac function. Methods: A total of 83 patients with atrial fibrillation with sinus rhythm were randomly divided into control group (n = 41) and treatment group (n = 42). The control group was treated with amiodarone alone. The treatment group was given Shensong Yangxin Capsule combined with amiodarone. The changes of atrial fibrillation and paroxysmal atrial fibrillation, left ventricular end-diastolic diameter, left ventricular ejection fraction, serum brain natriuretic peptide (BNP) and ambulatory electrocardiogram after 6 months of treatment. Results: The incidence of atrial fibrillation in treatment group was significantly lower than that in control group (P <0.05). There was no significant difference in left ventricular diastolic dimension and left ventricular ejection fraction between two groups, but serum BNP in treatment group was significantly higher than that in control group <0.05). Conclusion: Shensongyangxin capsule combined with amiodarone can effectively prevent the recurrence of atrial fibrillation, and can improve cardiac function.